asurgeryАмбулаторная хирургияAmbulatornaya khirurgiya = Ambulatory Surgery (Russia)2712-87412782-2591ООО «ГРУППА РЕМЕДИУМ»10.21518/1995-1477-2019-1-2-34-37asurgery-134Research ArticleФЛЕБОЛОГИЯ | АНГИОЛОГИЯPHLEBOLOGY | ANGIOLOGYВозможности терапии симптомов хронических заболеваний вен нижних конечностейPossibilities of treatment of symptoms of chronic diseases of lower limbs veinsКудыкинМ. Н.KudykinM. N.

Кудыкин Максим Николаевич – доктор медицинских наук, исполнительный директор общественной организации «Ассоциация ангиологов, флебологов и сосудистых хирургов Нижегородской области»; вице-президент  «Ассоциации флебологов России».

603141, Нижегородская область, Нижний Новгород, ул. Геологов, д.1, пом. п 29.

Kudykin Maxim Nikolayevich – Dr. of Sci. (Med), Executive Director of the public organization «Association of Angiologists, Phlebologists and Vascular Surgeons of Nizhny Novgorod Region»; Vice-President of «Association of Phlebologists of Russia».

603141, Nizhny Novgorod Region, Nizhny Novgorod, Geologov St., 1, bldg. 29.

mady5@yandex.ruАссоциация ангиологов, флебологов и сосудистых хирургов Нижегородской областиРоссияAssociation of Angiologists, Phlebologists and Vascular Surgeons of Nizhny Novgorod RegionRussian Federation20191204201901-23437Copyright © Кудыкин М.Н., 20192019Кудыкин М.Н.Kudykin M.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.a-surgeon.ru/jour/article/view/134

В обзоре представлены  литературные данные об эпидемиологии хронических заболеваний вен (ХЗВ) и хронической венозной недостаточности (ХВН). Приводятся основные подходы к выбору консервативной  терапии ХЗВ и ХВН. Обосновывается рациональность симптоматического лечения этой категории пациентов. Приводятся сведения о клинических эффектах и механизмах их реализации  у препарата добезилат  кальция.  Освещаются результаты доклинических и клинических исследований  по оценке эффективности и безопасности добезилата кальция в отношении симптоматического лечения ХЗВ и ХВН. На основании анализа литературных источников приводится вывод о целесообразности широкого применения добезилата кальция во флебологической практике.

The review presents literature on the epidemiology  of chronic venous diseases  (CVD) and chronic venous insufficiency (CVI). The main approaches to the  choice of conservative  therapy  for CVD and CVI are presented. The rationality of symptomatic treatment of this category of patients is justified. Data on clinical effects  and mechanisms  of their realization in the preparation of calcium dobesilate are given. The results  of preclinical and clinical studies to assess the efficacy and safety of calcium dobesilate in relation to the  symptomatic treatment of CVD and CVI are presented. On the  basis  of the  analysis  of literary  sources  the  conclusion  on expediency of wide application of calcium dobesilate in phlebological practice is presented.

хронические заболевания венхроническая венозная недостаточностькальция добезилатchronic vein diseaseschronic venous insufficiencycalcium dobesilateReferencesRabe E., Pannier F. Epidemiology of chronic venous disorders. In: Gloviczki P ed. Handbook of Venous Disorders. London: Hodder Arnold. 2009:105–110.Rabe E., Pannier F. Epidemiology of chronic venous disorders. In: Gloviczki P ed. Handbook of Venous Disorders. London: Hodder Arnold. 2009:105–110.Criqui M.H., Jamosmos M., Fronek A., et al. Chronic venous disease in an ethnically diverse population. The San Diego Population Study. Am J Epidemiol. 2003;158:448–56.Criqui M.H., Jamosmos M., Fronek A., et al. Chronic venous disease in an ethnically diverse population. The San Diego Population Study. Am J Epidemiol. 2003;158:448–56.Maurins U., Hoffmann B., Lösch C., Jöckel K.H., Rabe E., Pannier F. Distribution and prevalence of reflux in the superficial and deep venous system in the general population – results from the Bonn Vein Study. J Vasc Surg. 2008;48:680–7.Maurins U., Hoffmann B., Lösch C., Jöckel K.H., Rabe E., Pannier F. Distribution and prevalence of reflux in the superficial and deep venous system in the general population – results from the Bonn Vein Study. J Vasc Surg. 2008;48:680–7.Langer R.D., Ho E., Denenberg J.O., Fronek A., Allison M., Criqui M.H. Relationships between symptoms and venous disease: the San Diego population study. Arch Internal Med. 2005;165:1420–4.Langer R.D., Ho E., Denenberg J.O., Fronek A., Allison M., Criqui M.H. Relationships between symptoms and venous disease: the San Diego population study. Arch Internal Med. 2005;165:1420–4.Селиверстов Е.И., Авакъянц И.П., Никишков А.С., Золотухин И.А. Эпидемиология хронических заболеваний вен. Флебология. 2016;10(1):35-43.Seliverstov E.I., Avakyants I.P., Nikishkov A.S., Zolotukhin I.A. Epidemiology of chronic vein diseases. Phlebology [Flebologija]. 2016;10(1):35-43. (In Russ.)Золотухин И.А. Хронические заболевания вен у женщин: результаты российского скринингового исследования ДЕВА. Consilium Medicum. 2008;8:128-131.Zolotukhin I.A. Chronic Venous Diseases in Women: Results of the Russian DEVA screening study. Consilium Medicum. 2008;8:128-131. (In Russ.)Bollinger A., Herrig I., Fischer M., Hoffmann U., Franzeck U.K. Intravital capillaroscopy in patients with chronic venous insufficiency andlymphoedema: relevance to Daflon 500 mg. Int J Microcirc Clin Exp. 1995;15:41–4.Bollinger A., Herrig I., Fischer M., Hoffmann U., Franzeck U.K. Intravital capillaroscopy in patients with chronic venous insufficiency andlymphoedema: relevance to Daflon 500 mg. Int J Microcirc Clin Exp. 1995;15:41–4.Labs K.-H., Degischer S., Gamba G., Jaeger K.A. Effectiveness and safety of calcium dobesilate in treating chronic venous insufficiency: randomized, double-blind, placebo-controlled trial. Phlebology. 2004;19:123–30.Labs K.-H., Degischer S., Gamba G., Jaeger K.A. Effectiveness and safety of calcium dobesilate in treating chronic venous insufficiency: randomized, double-blind, placebo-controlled trial. Phlebology. 2004;19:123–30.Martínez-Zapata M.J., Moreno R.M., Gich I., Urrútia G., Bonfill X. Chronic Venous Insufficiency Study Group. A randomized, double-blind multicentre clinical trial comparing the efficacy of calcium dobesilate with placebo in the treatment of chronic venous disease. Eur J Vasc Endovasc Surg. 2008;35:358–65.Martínez-Zapata M.J., Moreno R.M., Gich I., Urrútia G., Bonfill X. Chronic Venous Insufficiency Study Group. A randomized, double-blind multicentre clinical trial comparing the efficacy of calcium dobesilate with placebo in the treatment of chronic venous disease. Eur J Vasc Endovasc Surg. 2008;35:358–65.Flota-Cervera F., Flota-Ruiz C., Trevino C., Berber A. Randomized, double blind, placebo-controlled clinical trial to evaluate the lymphagogue effect and clinical efficacy of calcium dobesilate in chronic venous disease. Angiology. 2008;59(3):352-356.Flota-Cervera F., Flota-Ruiz C., Trevino C., Berber A. Randomized, double blind, placebo-controlled clinical trial to evaluate the lymphagogue effect and clinical efficacy of calcium dobesilate in chronic venous disease. Angiology. 2008;59(3):352-356.Alda O., Valero M.S., Pereboom D., Serrano P., Azcona J.M., Garay R.P. In vitro effect of calcium dobesilate on oxidative/ inflammatory stress in human varicose veins. Phlebology. 2011;26(8):332-3337. doi:10.1258/phleb.2010.010052.Alda O., Valero M.S., Pereboom D., Serrano P., Azcona J.M., Garay R.P. In vitro effect of calcium dobesilate on oxidative/ inflammatory stress in human varicose veins. Phlebology. 2011;26(8):332-3337. doi:10.1258/phleb.2010.010052.Rabe E., Jaeger K.A., Bulitta M., Pannier F. Calcium dobesilate in patients suffering from chronic venous insufficiency: a double-blind, placebo-controlled, clinical trial. Phlebology. 2011;26(4):162-8. doi:10.1258/phleb.2010.010051.Rabe E., Jaeger K.A., Bulitta M., Pannier F. Calcium dobesilate in patients suffering from chronic venous insufficiency: a double-blind, placebo-controlled, clinical trial. Phlebology. 2011;26(4):162-8. doi:10.1258/phleb.2010.010051.Rabe E., Ballarini S., Lehr L. A randomized, double-blind, placebo-controlled, clinical study on the efficacy and safety of calcium dobesilate in the treatment of chronic venous insufficiency. Phlebology. 2016;31(4): 264-274. doi:10.1177/0268355515586097.Rabe E., Ballarini S., Lehr L. A randomized, double-blind, placebo-controlled, clinical study on the efficacy and safety of calcium dobesilate in the treatment of chronic venous insufficiency. Phlebology. 2016;31(4): 264-274. doi:10.1177/0268355515586097.Akbulut В. Calcium dobesilate and oxerutin: effectiveness of combination therapy Phlebology. 2010;25(2):66-71. doi:10.1258/phleb.2009.008085.Akbulut В. Calcium dobesilate and oxerutin: effectiveness of combination therapy Phlebology. 2010;25(2):66-71. doi:10.1258/phleb.2009.008085.Allain H., Ramelet A.A., Polard E., Bentue-Ferrer D. Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids. Drug Safety. 2004;27(9):649-660. doi:10.2165/00002018-200427090-00003.Allain H., Ramelet A.A., Polard E., Bentue-Ferrer D. Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids. Drug Safety. 2004;27(9):649-660. doi:10.2165/00002018-200427090-00003.Российские клинические рекомендации по диагностике и лечению хронических заболеваний вен. Флебология. 2018;3(3):143-240.Russian Clinical Recommendations for Diagnostics and Treatment of Chronic Venous Diseases. Phlebology [Flebologija]. 2018;3(3):143-240. (In Russ.)

The authors declare that there are no conflicts of interest present.